A Comparison of Lithium and T<char aid="99818416" id="sub">3</char> Augmentation Following Two Failed Medication Treatments for Depression: A STAR*D Report
The DOI matches its Crossref record.
Abstract
Objective: More than 40% of patients with major depressive disorder do not achieve remission even after two optimally delivered trials of antidepressant medications. This study compared the effectiveness of lithium versus triiodothyronine (T 3 ) augmentation as a third-step treatment for patients with major depressive disorder. Method: A total of 142 adult outpatients with nonpsychotic major depressive disorder who had not achieved remission or who were intolerant to an initial prospective treatment with citalopram and a second switch or augmentation trial were randomly assigned to augmentation with lithium (up to 900 mg/day; N=69) or with T 3 (up to 50 μg/day; N=73) for up to 14 weeks. The primary outcome measure was whether participants achieved remission, which was defined as a score ≤7 on the 17-item Hamilton Depression Rating Scale. Results: After a mean of 9.6 weeks (SD=5.2) of treatment, remission rates were 15.9% with lithium augmentation and 24.7% with T 3 augmentation, although the difference between treatments was not statistically significant. Lithium was more frequently associated with side effects (p=0.045), and more participants in the lithium group left treatment because of side effects (23.2% versus 9.6%; p=0.027). Conclusions: Remission rates with lithium and T 3 augmentation for participants who experienced unsatisfactory results with two prior medication treatments were modest and did not differ significantly. The lower side effect burden and ease of use of T 3 augmentation suggest that it has slight advantages over lithium augmentation for depressed patients who have experienced several failed medication trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 48
- Depression Guidelines Panel, 1993, Md, US Department of Health and Human Services, Public Health Service
- Nierenberg AA, 1999, J Clin Psychiatry, 60, 7, 10.4088/JCP.v60n0403 · DOI · Paper page
- 10.1056/NEJMoa052964 · DOI · Paper page
- 10.1111/j.1600-0447.2005.00676.x · DOI
- 10.1192/bjp.138.3.252 · DOI · Paper page
- Bschor T, 2003, Pharmacopsychiatry, 36, S230, 10.1055/s-2003-45135 · DOI · Paper page
- 10.1176/appi.ajp.157.9.1429 · DOI · Paper page
- 10.1097/00004714-200208000-00008 · DOI · Paper page
- 10.1176/ajp.114.9.841 · DOI
- 10.1176/ajp.126.4.457 · DOI · Paper page
- Howland RH, 1993, J Clin Psychiatry, 54, 47
- 10.2190/6FK8-DBGL-MWR1-MV58 · doi:10.2190/6fk8-dbgl-mwr1-mv58
- 10.1192/bjp.163.5.574 · DOI
- 10.1017/S1461145700001875 · DOI
- 10.4088/JCP.v66n0812 · DOI · Paper page
- 10.1001/archpsyc.1996.01830090090013 · DOI · Paper page
- 10.1176/appi.ajp.158.10.1617 · DOI · Paper page
- 10.1210/jc.2004-1147 · DOI · Paper page
- 10.1176/appi.ajp.161.11.2060 · DOI
- 10.1097/00004714-200302000-00013 · DOI · Paper page
- 10.1001/archpsyc.1993.01820170065008 · DOI · Paper page
- 10.1176/appi.ajp.163.1.28 · DOI · Paper page
- 10.1056/NEJMoa052963 · DOI · Paper page
- 10.1176/ajp.2006.163.7.1161 · DOI · Paper page
- 10.1016/S0193-953X(02)00107-7 · DOI · Paper page
- 10.1016/S0197-2456(03)00112-0 · DOI · Paper page
- 10.1002/mpr.79 · DOI · Paper page
- 10.1016/S0006-3223(02)01866-8 · DOI · Paper page
- 10.1017/S0033291703001107 · DOI · Paper page
- 10.1016/S0006-3223(01)01223-9 · DOI
- Trivedi MH, 2002, Wisniewski SR
- Trivedi MH, 2006, DeVeaugh-Geiss J
- 10.1016/j.biopsych.2005.08.022 · DOI · Paper page
- 10.1097/00131746-200603000-00002 · DOI · Paper page
- 10.1191/1740774504cn035oa · DOI · Paper page
- 10.1111/j.1532-5415.1968.tb02103.x · DOI · Paper page
- 10.1016/0165-1781(92)90005-N · DOI · Paper page
- 10.1001/archpsyc.58.8.787 · DOI · Paper page
- 10.1053/comp.2001.23126 · DOI · Paper page
- 10.1016/j.jad.2005.03.005 · DOI · Paper page
- 10.1097/00005650-199603000-00003 · DOI · Paper page
- 10.2165/00019053-199304050-00006 · DOI · Paper page
- 10.1192/bjp.180.5.461 · DOI · Paper page
- Endicott J, 1993, Psychopharmacol Bull, 29, 321
- 10.1176/ps.48.5.611 · DOI · Paper page
- Kobak KA, 1999, MD Comput, 16, 64
- 10.1136/jnnp.23.1.56 · DOI · Paper page
- 10.1017/S0033291700035558 · DOI · Paper page
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Pharmacogenetics of antidepressants
Crisafulli, C., Fabbri, C., Porcelli, S., Drago, A., Spina, E., De Ronchi, D., & Serretti, A. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00006 · Cited by 113
Mechanisms of antidepressant resistance
El-Hage, W., Leman, S., Camus, V., & Belzung, C. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00146 · Cited by 111
Pigott, H. E., Kim, T., Xu, C., Kirsch, I., & Amsterdam, J. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-063095 · Cited by 93
Kozel, F. A., Rao, U., Lu, H., Nakonezny, P. A., Grannemann, B., McGregor, T., Croarkin, P. E., Mapes, K. S., Tamminga, C. A., & Trivedi, M. H. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00007 · Cited by 61
Metadata
- Authors
- Nierenberg, A.
- Venue
- American Journal of Psychiatry
- Published
- 2006-09-01
- Volume
- 163
- Issue
- 9
- Pages
- 1519
- ISSN
- 0002-953X (ISSN-L)
- OpenAlex
- W4254340354
- Cited by
- 69
- References
- 0
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Comparison of Lithium and T<char aid="99818416" id="sub">3</char> Augmentation Following Two Failed Medication Treatments for Depression: A STAR*D Report. https://app.cochat.ai/papers/10.1176/appi.ajp.163.9.1519
- The paper
- Nierenberg, A. (2006). A Comparison of Lithium and T<char aid="99818416" id="sub">3</char> Augmentation Following Two Failed Medication Treatments for Depression: A STAR*D Report. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.163.9.1519
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.